Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Melatonin may be beneficial for improving memory performance

Staff Writer
Staff Writer 1 year ago
Updated 2021/10/23 at 2:11 PM
Share
SHARE

A newly released study in the Journal of Pineal Research provides a glimpse at the reportedly efficacious effects of melatonin in instances of cognitive decline among rodents.

Organized and conducted at the Tokyo Medical and Dental University, the study probed the acute effects of melatonin, while also evaluating the levels of the dietary-based treatment in the hippocampus and temporal lobe regions of the brain.

“We know that melatonin is converted into N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK) in the brain,” said one of the researchers in a press release. “and we suspected that they might promote cognition.”

During the study, rodents were given doses of melatonin, evaluating their memory function the following day.

The findings uncovered memory improvements after treatment with melatonin, with N1-acetyl-5-methoxykynuramine being the most beneficial.

The study’s findings, researchers proclaimed, indicate that melatonin may be able to effectively facilitate memory formation in rodents and could be beneficial for long-term memory in older adults, however, future research is warranted.

“Its effect on older mice is particularly encouraging and we are hopeful that future studies will show similar effects in older people. If this happens, AMK therapy could eventually be used to reduce the severity of Mild Cognitive Impairment and its potential conversion to Alzheimer’s disease,” the researchers determined.

Photo: Image copyright by Hank Grebe, 2019

You Might Also Like

Type 2 diabetes may lead to a significant increase in brain aging and cognitive decline

Study finds no structural brain change during mindfulness-based stress training

Study finds diet may be a contributing factor in ADHD symptoms associated in children

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

ALS experimental drug NU-9 more efficacious than existing FDA-approved drugs

TAGGED: melatonin, cognition, memory
Staff Writer December 10, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article The intensity of Facebook use correlated with trust in the social platform
Next Article Young adults with higher social support less likely to experience mental health adversities

Recommended

Clinical

Type 2 diabetes may lead to a significant increase in brain aging and cognitive decline

1 Min Read
Clinical

Study finds no structural brain change during mindfulness-based stress training

1 Min Read
Clinical

Study finds diet may be a contributing factor in ADHD symptoms associated in children

1 Min Read
Clinical

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?